PARSIPPANY, N.J., Dec. 13, 2012 /PRNewswire/ -- As part of its annual "New Jersey's 50 Fastest Growing Companies" awards, NJBIZ recently named Ferring Pharmaceuticals the 10th Fastest Growing Company in New Jersey based on revenue growth as well as its consistent contribution to the success of the state's economic growth and stability.
"Ferring is committed to the state of New Jersey, " said Aaron Graff, President and COO of Ferring Pharmaceuticals Inc. "We are proud of the work we do, proud to be doing it in Morris County and proud of our continued investment in New Jersey."
As evidence of its ongoing commitment, Ferring recently purchased a 25-acre site in Parsippany to house its new state-of-the-art US Operations Center. The new facility will generate jobs in the New Jersey area and house key functions including next-generation product development laboratories.
The company credits its R&D investment, both in terms of people and technology, as an important driver of its continued revenue growth. Ferring's dedication to science helps it to develop new, innovative products to treat unmet medical needs. In addition to R&D, Ferring has formed alliances with pharmaceutical and biotech companies as well as academic institutions as a means of growing the business.
To learn more about the Ferring Pharmaceuticals, visit www.ferringUSA.com.
About Ferring Pharmaceuticals
Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of reproductive health, urology, gastroenterology, endocrinology and osteoarthritis. For more information, visit www.ferringUSA.com.
SOURCE Ferring Pharmaceuticals